Close Menu

Link Technologies

The company will integrate the oligonucleotide manufacturer with two of its existing sections to form a new Nucleic Acid Chemistry business unit.

The reagent supplier now has three Japanese distributors following a 2013 deal with GeneDesign as a representative throughout that country.

NEW YORK (GenomeWeb News) – Following its first distribution deal for Asia, Link Technologies today announced another deal covering that region, this time with Japanese firm GeneDesign

NEW YORK (GenomeWeb News) – Link Technologies today announced that it has signed on Zirench Technology to be its distributor in China.

NEW YORK (GenomeWeb News) – Link Technologies today announced a deal with American International Chemical for the distribution of some Link products in North America.

Under the terms of the agreement, Link will manufacture and sell diagnostic reagents based on the so-called exciplex technology, which is able to reduce the background fluorescent signal in nucleic acid assays in order to improve the detection sensitivity.

The company will make and sell a Manchester-developed diagnostic reagent technology through an agreement that includes a research collaboration.

Link will make and market reagents using RiboTask's UNA monomer technology.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.